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3036Objectives: The Society of Thoracic Surgeons 2008 cardiac surgery risk models have been developed for heart
valve surgery with and without coronary artery bypass grafting. The aim of our study was to evaluate the
performance of Society of Thoracic Surgeons 2008 cardiac risk models in Chinese patients undergoing single
valve surgery and the predicted mortality rates of those undergoing multiple valve surgery derived from the
Society of Thoracic Surgeons 2008 risk models.
Methods: A total of 12,170 patients underwent heart valve surgery from January 2008 to December 2011.
Combined congenital heart surgery and aortal surgery cases were excluded. A relatively small number of valve
surgery combinations were excluded. The final research population included the following isolated heart valve
surgery types: aortic valve replacement, mitral valve replacement, and mitral valve repair. The following
combined valve surgery types were included: mitral valve replacement plus tricuspid valve repair, mitral valve
replacement plus aortic valve replacement, and mitral valve replacement plus aortic valve replacement and
tricuspid valve repair. Evaluation was performed by using the Hosmer–Lemeshow test and C-statistics.
Results: Data from 9846 patients were analyzed. The Society of Thoracic Surgeons 2008 cardiac risk models
showed reasonable discrimination and poor calibration (C-statistic, 0.712; P ¼ .00006 in Hosmer–Lemeshow
test). Society of Thoracic Surgeons 2008 models had better discrimination (C-statistic, 0.734) and calibration
(P ¼ .5805) in patients undergoing isolated valve surgery than in patients undergoing multiple valve surgery
(C-statistic, 0.694; P ¼ .00002 in Hosmer–Lemeshow test). Estimates derived from the Society of Thoracic
Surgeons 2008 models exceeded the mortality rates of multiple valve surgery (observed/expected ratios of
1.44 for multiple valve surgery and 1.17 for single valve surgery).
Conclusions: The Society of Thoracic Surgeons 2008 cardiac surgery risk models performed well when predict-
ing the mortality for Chinese patients undergoing valve surgery. The Society of Thoracic Surgeons 2008 models
were suitable for single valve surgery in a Chinese population; estimates of mortality for multiple valve surgery
derived from the Society of Thoracic Surgeons 2008 models were less accurate. (J Thorac Cardiovasc Surg
2014;148:3036-41)The Society of Thoracic Surgeons (STS) Predicted Risk of
Mortality (PROM) is a standard risk prediction algorithm
for patients undergoing isolated coronary artery bypass
grafting (CABG), isolated valve replacement, and CABG
plus valve replacement and is based on the STS National
Adult Cardiac Surgery Database, one of the largest
specialty-specific clinical data registries in the world with
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The Journal of Thoracic and Cardiovascular Surcardiac surgery risk models were published in 2009, based
on STS National Adult Cardiac Surgery Database version
2.61. They include new valve and valve plus CABG surgery
models that differentiate between mitral valve replacement
(MVR) and repair1 and show great improvement in
model discrimination compared with the previous STS
risk models.2-4
The STS-PROM and the European System for
Cardiac Operation Risk Evaluation (euroSCORE), another
successful risk evaluation system used worldwide, have
clearly demonstrated good predictive ability when applied
to patients with coronary artery disease.5,6 Recent studies
concerning valve surgery mortality have shown that STS-
PROM outperforms not only the euroSCORE but also other
cardiac risk prediction models, such as the Ambler score,
Providence score, and Veterans Administration score,
when applied to aortic valve replacement (AVR).7-10
Rheumatic heart disease, which usually affects heart
valves, is the primary reason for heart surgery in China.gery c December 2014
Abbreviations and Acronyms
AVR ¼ aortic valve replacement
CABG ¼ coronary artery bypass grafting
CI ¼ confidence interval
euroSCORE ¼ European System for Cardiac
Operation Risk Evaluation
MVR ¼ mitral valve replacement
MVRepair ¼ mitral valve repair
O/E ¼ observed/expected
PROM ¼ Predicted Risk of Mortality
STS ¼ Society of Thoracic Surgeons
TVRepair ¼ tricuspid valve repair
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DMultiple valve surgery for rheumatic heart disease
comprises approximately two fifths of all heart valve
surgery procedures in China. The aim of this study was to
validate the STS 2008 cardiac risk models in a contempo-
rary group of patients undergoing heart valve surgery,
including AVR, MVR, mitral valve repair (MVRepair),
AVR þ MVR, MVR þ tricuspid valve repair (TVRepair),
and MVR þ AVR þ TVRepair, and to evaluate whether
STS-PROM accurately predicts in-hospital mortality in a
Chinese population. Although the STS 2008 risk
models were not designed for multiple valve surgery, we
decided to study their performance in both the Chinese
isolated and multiple valve populations. For multiple valve
surgery, if they perform acceptably, they could be used until
formal STS risk models for multiple valve procedures are
released.
PATIENTS AND METHODS
Patient Population and Data
In the current study, all adult patients who underwent heart valve
surgery between January 2008 and December 2011 at 4 cardiac surgery
centers were included: Fu Wai Hospital in Beijing, Changhai Hospital of
Shanghai, Zhongshan Hospital of Fudan University in Shanghai, and
Cuangdong Cardiovascular Institute in Guangzhou. To meet all require-
ments for the STS 2008 models, we excluded patients with concomitant
aortic or congenital heart surgery. Patients who underwent isolated heart
valve surgery other than AVR, MVR, and MVRepair also were excluded.
Combined valve surgery other than MVR plus TVRepair, AVR plus
MVR, and AVR plus MVR and TVRepair were excluded because of their
relatively small numbers.
Information on patients and the procedural risk factors for all
patients were collected retrospectively, resulting in a completely retro-
spective dataset stored in a local cardiac valve database. Patients
who underwent single valve surgery were separated from those who
underwent multiple valve surgery; thus, 2 patient groups were created
in this database. The predictive mortality rate for every patient in this
study was calculated using the published STS 2008 cardiac surgery
risk models, including their risk factor definition and predictive risk
calculation formula.2,3 Because valve surgery combined with CABG
accounted for a small fraction of the total valve surgery procedures,
valve surgery combined with and without CABG was merged for
model validation. In-hospital mortality was the dependent variable in
this study.The Journal of Thoracic and CarData Analysis
The discriminatory power of the model was assessed with the
C-statistic (index of concordance) and 95% confidence intervals (CIs).
The C-statistic, or area under the receiver operating characteristic
curve, is the proportion of predictions that are concordant with the
observations. The value of the C-statistic ranges from 0.5 (no ability
to discriminate) to 1.0 (full ability to discriminate). The discriminative
power of the model is considered reasonable when the C-statistic is
more than 0.7 and strong when the C-statistic exceeds 0.8.11 Model
calibration was evaluated by the Hosmer–Lemeshow goodness-of-fit
test. All statistical analyses were performed with SPSS version 19.0
(SPSS Inc, Chicago, Ill).RESULTS
Patient Population
All 12,157 patients who underwent valve surgery
procedures between January 2008 and December 2011
were evaluated for study inclusion. Valve surgery combined
with aortic surgery and congenital heart procedures were
excluded from the dataset. AVR, MVR, MVRepair, MVR
plus TVRepair, MVR plus AVR, MVR plus AVR, and
TVRepair were included in this study, and they accounted
for approximately 81% of all valve surgery procedures
during this study. Finally, a database including 9846
patients was obtained. The baseline patient characteristics
of our study population and those of the STS 2008
cardiac surgery risk models are shown in Table 1. The
operation details for our study population are shown in
Table 2.Model Validation
The observed in-hospital mortality was 1.79% in all
patients (176 deaths in 9846 patients), and the predicted
mortality was 1.33%; the overall observed/expected
(O/E) ratio of in-hospital mortality was 1.34. In-hospital
mortality was 1.38% in the single valve surgery group
(54 deaths in 3917 patients) and 2.06% in the multiple
valve surgery group (122/5929 patients). The predicted
mortalities were 1.18% and 1.43%, respectively. The
O/E ratios of operative mortalities were 1.17 and 1.44,
respectively.
Discrimination. The C-statistics for the overall patient
population, the single valve surgery group, and the multiple
valve surgery group are shown in Table 2. The STS 2008
risk models showed better performance in the single valve
group (C-statistic, 0.734) than in the multiple valve group
(C-statistic, 0.694). Figure 1 shows the receiver operating
characteristic curves for the single valve surgery group,
multiple valve surgery group, and overall study population.
Calibration. The P values of the Hosmer–Lemeshow
goodness-of-fit tests for all patients, the single valve surgery
group, and the multiple valve surgery group were .0000645,
.58, and .018, respectively (Table 3). The STS 2008 risk
models proved to be well calibrated for the single valve
surgery group, whereas the derived estimates were poorlydiovascular Surgery c Volume 148, Number 6 3037
TABLE 1. Distribution of risk factors in our study population versus
Society of Thoracic Surgeons 2008 models
Variable
No. of
patients
Proportion of risk factors present
in STS 2008 risk models
N %
Isolated valve
surgery (%)
Valve surgery
plus CABG (%)
All patients 9846 100 n ¼ 109,759 n ¼ 101,661
Age (y)
<55 6182 62.8 25.6 6.6
55-64 2733 27.8 21.2 16.9
65-74 865 8.7 25.6 33.1
75 66 0.7 27.5 43.4
Sex
Male 4458 45.3 55.4 64.5
Female 5388 54.7 44.6 35.5
Body surface area (m2)
<1.50 2310 23.5 4.0 3.3
1.50-1.74 4876 49.5 22.4 20.4
1.75-1.99 2360 24.0 36.9 39.4
2.00 300 3.0 36.0 36.4
Body mass index (kg/m2)
<25 7609 77.3 32.4 28.9
25-29 2034 20.7 35.6 38.7
30-34 191 1.9 18.7 20.7
35 12 0.1 12.5 11.0
Renal function (creatinine, mg/dL)
<1.00 7488 76.0 38.3 29.7
1-1.49 2197 22.3 47.3 51.2
1.5-1.99 114 1.2 7.4 11.3
2-2.49 33 0.3 1.8 2.7
2.5 14 0.1 1.2 1.6
No. of diseased coronary vessels
0 9627 97.7 82.3 2.3
1 107 1.1 8.2 22.3
2 112 1.1 3.1 26.7
3 0 0 5.1 48.3
Ejection fraction%
<25 5 0.1 2.5 5.7
25-34 71 0.7 5.4 10.8
35-44 371 3.8 9.1 14.7
45-54 1359 13.8 18.7 20.1
55 8040 81.7 55.5 42.8
NYHA
I 2211 22.5 15.9 9.7
II 2889 29.3 29.5 24.4
III 4382 44.5 36.7 41.9
IV 364 3.7 13.1 20.2
Combined CABG 359 3.6
CABG, Coronary artery bypass grafting; NYHA, New York Heart Association;
STS, Society of Thoracic Surgeons.
TABLE 2. Operation details for the study population
Frequency Proportion (%)
AVR 1830 18.6
MVR 1475 15.0
MVRepair 612 6.2
MVR þ TVRepair 2828 28.7
MVR þ AVR 1201 12.2
MVR þ AVR þ TVRepair 1900 19.3
AVR, Aortic valve replacement; MVR, mitral valve replacement; MVRepair, mitral
valve repair; TVRepair, tricuspid valve repair.
FIGURE 1. Receiver operating characteristic curve of STS 2008 models
for valve surgery: all patients, 0.712; single valve surgery group, 0.734;
multiple valve surgery group, 0.694.
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Dcalibrated for the multiple valve surgery group and the
overall group. The calibration plots (observed vs expected)
are presented in Figure 2.
The clinical performance of the STS 2008 cardiac
surgery risk models was tested for patients with different
predicted mortality (Figure 3). The overall population and3038 The Journal of Thoracic and Cardiovascular Surthe 2 subgroups were divided into quintiles according to
their STS-predicted mortality. Then the observed mortality
was compared with the predicted mortality. The best
agreement between observed and expected mortality was
achieved in patients in the single valve surgery group with
mild-to-moderate predicted mortality risk (between 0.5%
and 1%). An approximate prediction was found for
low-risk patients in the overall population with predicted
mortality less than 0.9%. The STS produced a predicted
mortality lower than the observed mortality in patients at
high to very high risk in both the single valve surgery group
and the multiple valve surgery group.DISCUSSION
The main results of our study are that (1) the STS 2008
cardiac surgery risk models can be used as a risk prediction
tool for patients in a Chinese population undergoing cardiac
valve surgery and that (2) the STS 2008 cardiac surgery
models and the derived estimates show more predictivegery c December 2014
TABLE 3. Mortality predictive statistics of Society of Thoracic Surgeons 2008 models for the study population
C-statistic
P value of Hosmer–Lemeshow
goodness-of-fit test
Observed
mortality (%)
Expected
mortality (%) O/E ratio
All procedures 0.712 (0.647-0.750) .00006 1.79 1.33 1.34
Single valve surgery 0.734 (0.670-0.799) .5805 1.38 1.18 1.17
Multiple valve surgery 0.694 (0.644-0.744) .00002 2.06 1.43 1.44
O/E, Observed/expected.
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procedures.
The STS-PROM is one of the most widely used risk
prediction tools for patients undergoing cardiac surgery.
It plays an important role in current clinical practice
and has been used to predict postoperative risk, stratify
‘‘high-risk’’ patients for alternative therapy strategies, and
evaluate the impact of risk factors on operation outcomes12
and as a benchmark for hospital performance.13 With its
high degree of accuracy, the model also became the entry
criteria for patients in the Transcatheter Aortic Valve
Implantation device trial in the United States. Because the
published STS 2008 cardiac surgery risk models have not
been well validated in a Chinese population, it is meaning-
ful to evaluate whether the STS 2008 cardiac surgery risk
models can provide sufficient predictive power for Chinese
patients undergoing valve surgery. Our study population
was selected from 4 institutions located in East China, the
developed area of China, and the population was drawn
from approximately half of the area of China. We believe
that our study results are representative of the Chinese
population.
In regard to the ethnicity, epidemiology, and medical
treatment difference between patients in our institutions
and patients in the STS database, the baseline characteris-
tics in our institutions differed from those of the STS
population. The population included in our study was
younger and had less renal dysfunction, higher ejectionFIGURE 2. Calibration plots of STS 2008 risk models: The calibration plots o
that exceeds 45 than calibration plots for all patients and the multiple valve gr
The Journal of Thoracic and Carfractions, less coronary artery disease, and better New
York Heart Association levels than those in the STS models
(Table 1). There were more patients with a low risk of
in-hospital death in our study population and fewer at
high risk (patients with predicted hospital mortality
>10% accounted for 0.25% of study population). These
differences may account for some of the decreased
predictive power of the STS-PROM in our overall study
population.
The STS-PROM underestimated the mortality (O/E ratio
of 1.34) of the overall study population. The C-statistic was
0.712 (95% CI, 0.674-0.750), and the Hosmer–Lemeshow
test demonstrated a lack of calibration (P ¼ .0000645).
The internal model discrimination of the STS 2008 models
was strong for the isolated valve surgery model (C-statistic,
0.799 in the validation sample and 0.805 in the development
sample) and good in valve surgery plus CABG (C-statistic,
0.750 in the validation sample and 0.754 in the development
sample).2-4 This demonstrated that the STS 2008 cardiac
risk models have less discriminatory power in our study
population than in the STS population. A validation of the
euroSCORE in Chinese patients undergoing valve surgery
was performed by Wang and colleagues14 and resulted in
poor predictive power; the STS 2008 models showed a
better performance than the euroSCORE in Chinese
patients undergoing valve surgery (C-statistic, 0.712 for
STS 2008 models in this study vs 0.64 for the euroSCORE
in their study). Taken together, the STS 2008 models aref STS 2008 for the single valve surgery group were closer to a straight line
oup.
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FIGURE 3. Clinical performance of STS 2008 models for patient subgroups according to mortality risk. CI, Confidence interval; STS, Society of Thoracic
Surgeons.
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undergoing single valve surgery, with STS-predicted
mortality ranging from 0.5% to 1%.
Rheumatic heart disease, which does not influence a
particular valve, remains the key cause of heart valve
disease at our institutions. Multiple valve procedures
are common, because MVR þ AVR þ TVRepair, MVR þ
TVRepair, and MVR þ AVR account for approximately
49.8% of all valve procedures in our study population.
Multiple valve procedures were not included in the STS
2008 cardiac surgery models because that accounted for a
small number of procedures in the STS database, and the
risk prediction algorithm of single valve surgery may lead
to a decrease in predictive power if applied in multiple valve
surgery. Therefore, we validated single valve procedures
and multiple valve procedures separately. The C-statistic
was 0.734 (95% CI, 0.670-0.799), the P value of the
Hosmer–Lemeshow goodness-of-fit test was .58, and the
O/E ratio was 1.18 in the single valve surgery group; this
means that the STS-PROM fits well with our study
population for single valve surgery in both discrimination
and calibration. Studying model validation in aortic valve
surgery10 suggested that the STS-PROM showed better
discrimination than the euroSCORE in predicting hospital
mortality (C-statistic, 0.73 for STS 2008 models vs 0.68
for euroSCORE). This result was similar to that of our study,
because single valve procedures showed a C-statistic of
0.734, which was not as good as that in the STS population
(C-statistics of 0.805 for development sample and 0.799
for validation sample in the isolated valve group, 0.754 for
development sample, and 0.750 in validation sample in the
valve plus CABG group).2,3
In this study, validation of the STS 2008 models in the
multiple valve surgery group showed poor discrimination3040 The Journal of Thoracic and Cardiovascular Sur(C-statistic, 0.678; 95% CI, 0.628-0.729), poor calibration
(Hosmer–Lemeshow test: P¼ .018), and significantly over-
estimated mortality (O/E 1.43). Multiple valve surgery was
more complex than single valve surgery, and the cardiopul-
monary bypass times usually were longer, leading to
increased injury to the myocardium. Recent studies indicate
that cardiopulmonary bypass time was a significant early
mortality risk factor in patients undergoing CABG or valve
surgery.15,16 Pulmonary artery hypertension was proved to
be a risk factor to the outcome of aortic valve surgery,17
and the absence of pulmonary artery hypertension in the
STS 2008 risk models might be part of the reason that it
had relatively poor performance in our study population.
The absence of a complexity factor for the surgical proce-
dures presented in the STS 2008 models may be the reason
that the STS 2008 models are inferior with multivalve pro-
cedures. The complexity of the procedure is a predictor of
operativemortality in the euroSCORE II18 but is not consid-
ered in STS 2008 models. The creators of the STS 2008
models used another method to resolve complexity; they
established specific models for each procedure: isolated
valve surgery, CABG, and valve surgery plus CABG. The
specificity of these models might restrict the application
of STS 2008 models to other types of cardiac surgery.
Study Limitations
This study validated only mortality; 8 of the 9 other end
points that the STS cardiac surgery risk models provide
were not validated. Combined valve surgery and CABG
accounted for approximately 3% of our study population,
so this group could not be accurately validated in this study.
For the reasons mentioned, the true performance of the STS
2008 cardiac risk models in the Chinese population may
have been biased.gery c December 2014
Wang et al Acquired Cardiovascular DiseaseCONCLUSIONS
The STS 2008 cardiac surgery risk models are an excel-
lent risk-evaluation system for assessing the risk of
morbidity and mortality after cardiac surgery, including
valve surgery, CABG, and valve surgery and CABG
together. The STS 2008 cardiac risk models performed
well when predicting the mortality for Chinese patients
who underwent valve surgery.As the baseline characteristics
differed in the study populations and STS population, the
STS 2008 models were more suitable for single valve sur-
gery than formultiple valve surgery in a Chinese population.
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